A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis

Archives of Neurology

Volumn 63, Issue 12, 2006, Pages 1719-1722

  Hideyama, Takuto ^a,c   Momose, Toshimitsu ^b   Shimizu, Jun ^a   Tsuji, Shoji ^a   Kwak, Shin ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLSPIPERONE C 11; FLUORINE 18; FLUORINE F 18 LEVODOPA; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEVODOPA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE LESION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPIPERONE; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845521099     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.12.1719     Document Type: Article

References (13)

1. Eisen A, Calne D. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sci. 1992;19(1 Suppl):117-123.
2. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG. Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol (Berl). 1995;89: 275-283.
3. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 1993;342:1016-1018.
4. Brooks BR. Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS, Versailles 2nd Consensus Conference participants. Amyotroph Lateral Scler Other Motor Neuron Disord. March 2000:(suppl 1):S79-S81.
5. Yoshimura M, Yamamoto T, Iso-o N, et al. Hemiparkinsonism associated with a mesencephalic tumor. J Neurol Sci. 2002;197:89-92.
6. Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology. 2004;24:87-102.
7. Dick JP, Benecke R, Rothwell JC, Day BL, Marsden CD. Simple and complex movements in a patient with infarction of the right supplementary motor area. Mov Disord. 1986;1:255-266.
8. Jenkins IH, Fernandez W, Playford ED, et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol. 1992;32:749-757.
9. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: a PET study. Brain. 1996;119:2105-2120.
10. Vercelletto M, Ronin M, Huvet M, Magne C, Feve JR. Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases. Eur J Neurol. 1999;6:295-299.
11. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077-1079.
12. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001; 58:1803-1809.
13. Mackenzie IR, Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol (Berl). 2003;105:98-102.